Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

515 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational locking.
Liu L, Casner RG, Guo Y, Wang Q, Iketani S, Chan JF, Yu J, Dadonaite B, Nair MS, Mohri H, Reddem ER, Yuan S, Poon VK, Chan CC, Yuen KY, Sheng Z, Huang Y, Bloom JD, Shapiro L, Ho DD. Liu L, et al. Among authors: mohri h. Immunity. 2023 Oct 10;56(10):2442-2455.e8. doi: 10.1016/j.immuni.2023.09.003. Epub 2023 Sep 29. Immunity. 2023. PMID: 37776849 Free PMC article.
Resistance of SARS-CoV-2 omicron subvariant BA.4.6 to antibody neutralisation.
Wang Q, Li Z, Ho J, Guo Y, Yeh AY, Mohri H, Liu M, Wang M, Yu J, Shah JG, Chang JY, Herbas F, Yin MT, Sobieszczyk ME, Sheng Z, Liu L, Ho DD. Wang Q, et al. Among authors: mohri h. Lancet Infect Dis. 2022 Dec;22(12):1666-1668. doi: 10.1016/S1473-3099(22)00694-6. Epub 2022 Oct 31. Lancet Infect Dis. 2022. PMID: 36328002 Free PMC article. No abstract available.
Antibody neutralisation of emerging SARS-CoV-2 subvariants: EG.5.1 and XBC.1.6.
Wang Q, Guo Y, Zhang RM, Ho J, Mohri H, Valdez R, Manthei DM, Gordon A, Liu L, Ho DD. Wang Q, et al. Among authors: mohri h. Lancet Infect Dis. 2023 Oct;23(10):e397-e398. doi: 10.1016/S1473-3099(23)00555-8. Epub 2023 Sep 11. Lancet Infect Dis. 2023. PMID: 37708906 No abstract available.
Emergence and Expansion of the SARS-CoV-2 Variant B.1.526 Identified in New York.
Annavajhala MK, Mohri H, Wang P, Nair M, Zucker JE, Sheng Z, Gomez-Simmonds A, Kelley AL, Tagliavia M, Huang Y, Bedford T, Ho DD, Uhlemann AC. Annavajhala MK, et al. Among authors: mohri h. medRxiv [Preprint]. 2021 Aug 4:2021.02.23.21252259. doi: 10.1101/2021.02.23.21252259. medRxiv. 2021. PMID: 33655278 Free PMC article. Updated. Preprint.
Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir.
Duan Y, Zhou H, Liu X, Iketani S, Lin M, Zhang X, Bian Q, Wang H, Sun H, Hong SJ, Culbertson B, Mohri H, Luck MI, Zhu Y, Liu X, Lu Y, Yang X, Yang K, Sabo Y, Chavez A, Goff SP, Rao Z, Ho DD, Yang H. Duan Y, et al. Among authors: mohri h. Nature. 2023 Oct;622(7982):376-382. doi: 10.1038/s41586-023-06609-0. Epub 2023 Sep 11. Nature. 2023. PMID: 37696289
Dispensable role of Rac1 and Rac3 after cochlear hair cell specification.
Nakamura T, Sakaguchi H, Mohri H, Ninoyu Y, Goto A, Yamaguchi T, Hishikawa Y, Matsuda M, Saito N, Ueyama T. Nakamura T, et al. Among authors: mohri h. J Mol Med (Berl). 2023 Jul;101(7):843-854. doi: 10.1007/s00109-023-02317-4. Epub 2023 May 19. J Mol Med (Berl). 2023. PMID: 37204479 Free PMC article.
Antibodies that neutralize all current SARS-CoV-2 variants of concern by conformational locking.
Liu L, Casner RG, Guo Y, Wang Q, Iketani S, Chan JF, Yu J, Dadonaite B, Nair MS, Mohri H, Reddem ER, Yuan S, Poon VK, Chan CC, Yuen KY, Sheng Z, Huang Y, Bloom JD, Shapiro L, Ho DD. Liu L, et al. Among authors: mohri h. bioRxiv [Preprint]. 2023 Apr 10:2023.04.08.536123. doi: 10.1101/2023.04.08.536123. bioRxiv. 2023. PMID: 37090592 Free PMC article. Preprint.
515 results